Back to Search Start Over

The Assisi Think Tank Meeting Survey of post-mastectomy radiation therapy in ductal carcinoma in situ: Suggestions for routine practice

Authors :
Universitat Rovira i Virgili
Montero-Luis A; Aristei C; Meattini I; Arenas M; Boersma L; Bourgier C; Coles C; Cutuli B; Falcinelli L; Kaidar-Person O; Leonardi MC; Offersen B; Marazzi F; Rivera S; Tagliaferri L; Tombolini V; Vidali C; Valentini V; Poortmans P
Universitat Rovira i Virgili
Montero-Luis A; Aristei C; Meattini I; Arenas M; Boersma L; Bourgier C; Coles C; Cutuli B; Falcinelli L; Kaidar-Person O; Leonardi MC; Offersen B; Marazzi F; Rivera S; Tagliaferri L; Tombolini V; Vidali C; Valentini V; Poortmans P
Source :
Critical Reviews In Oncology Hematology; 10.1016/j.critrevonc.2019.04.016; Critical Reviews In Oncology Hematology. 138 207-213
Publication Year :
2019

Abstract

© 2019 Elsevier B.V. Background: Risk factors for local recurrence after mastectomy in ductal carcinoma in situ (DCIS) emerged as a grey area during the second “Assisi Think Tank Meeting” (ATTM) on Breast Cancer. Aim: To review practice patterns of post-mastectomy radiation therapy (PMRT) in DCIS, identify risk factors for recurrence and select suitable candidates for PMRT. Methods: A questionnaire concerning DCIS management, focusing on PMRT, was distributed online via SurveyMonkey. Results: 142 responses were received from 15 countries. The majority worked in academic institutions, had 5–20 years work-experience and irradiated <5 DCIS patients/year. PMRT was more given if: surgical margins <1 mm, high-grade, multicentricity, young age, tumour size >5 cm, skin- or nipple- sparing mastectomy. Moderate hypofractionation was the most common schedule, except after immediate breast reconstruction (57% conventional fractionation). Conclusions: The present survey highlighted risk factors for PMRT administration, which should be further evaluated.

Details

Database :
OAIster
Journal :
Critical Reviews In Oncology Hematology; 10.1016/j.critrevonc.2019.04.016; Critical Reviews In Oncology Hematology. 138 207-213
Publication Type :
Electronic Resource
Accession number :
edsoai.on1443574220
Document Type :
Electronic Resource